Med Life Past Earnings Performance
Past criteria checks 2/6
Med Life's earnings have been declining at an average annual rate of -15.4%, while the Healthcare industry saw earnings growing at 13% annually. Revenues have been growing at an average rate of 21.3% per year. Med Life's return on equity is 2.5%, and it has net margins of 0.8%.
Key information
-15.4%
Earnings growth rate
-13.9%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 21.3% |
| Return on equity | 2.5% |
| Net Margin | 0.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Is Med Life S.A. (BVB:M) Trading At A 41% Discount?
Aug 06
The Market Lifts Med Life S.A. (BVB:M) Shares 25% But It Can Do More
Jun 08Is Med Life (BVB:M) A Risky Investment?
Apr 05Returns On Capital Signal Tricky Times Ahead For Med Life (BVB:M)
Jul 05Is Med Life (BVB:M) A Risky Investment?
Jan 06Med Life (BVB:M) Hasn't Managed To Accelerate Its Returns
Dec 06We Think Med Life (BVB:M) Is Taking Some Risk With Its Debt
Sep 27Returns Are Gaining Momentum At Med Life (BVB:M)
May 05Is There An Opportunity With Med Life S.A.'s (BVB:M) 49% Undervaluation?
Mar 01Med Life (BVB:M) Shareholders Will Want The ROCE Trajectory To Continue
Jan 22Does Med Life (BVB:M) Have A Healthy Balance Sheet?
Aug 31Med Life's (BVB:M) Returns On Capital Are Heading Higher
Jun 10Here's Why We Think Med Life (BVB:M) Is Well Worth Watching
May 26Is Now An Opportune Moment To Examine Med Life S.A. (BVB:M)?
May 12Is There An Opportunity With Med Life S.A.'s (BVB:M) 24% Undervaluation?
Apr 12Update: Med Life (BVB:M) Stock Gained 98% In The Last Year
Mar 16Should We Be Excited About The Trends Of Returns At Med Life (BVB:M)?
Mar 04Should You Be Impressed By Med Life S.A.'s (BVB:M) ROE?
Feb 20
Med Life (BVB:M) Seems To Use Debt Quite Sensibly
Feb 07Is It Too Late To Consider Buying Med Life S.A. (BVB:M)?
Jan 25Do Med Life's (BVB:M) Earnings Warrant Your Attention?
Jan 08Is Med Life S.A. (BVB:M) Trading At A 22% Discount?
Dec 23Did You Miss Med Life's (BVB:M) 49% Share Price Gain?
Dec 08The Trends At Med Life (BVB:M) That You Should Know About
Nov 24Revenue & Expenses Breakdown
How Med Life makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 2,566 | 22 | 819 | 0 |
| 30 Jun 24 | 2,461 | 18 | 786 | 0 |
| 31 Mar 24 | 2,337 | 11 | 740 | 0 |
| 31 Dec 23 | 2,222 | 4 | 697 | 0 |
| 30 Sep 23 | 2,116 | -11 | 653 | 0 |
| 30 Jun 23 | 2,020 | -3 | 609 | 0 |
| 31 Mar 23 | 1,921 | 12 | 568 | 0 |
| 31 Dec 22 | 1,810 | 32 | 524 | 0 |
| 30 Sep 22 | 1,725 | 64 | 491 | 0 |
| 30 Jun 22 | 1,623 | 80 | 465 | 0 |
| 31 Mar 22 | 1,520 | 98 | 437 | 0 |
| 01 Jan 22 | 1,438 | 103 | 415 | 0 |
| 30 Sep 21 | 1,359 | 107 | 400 | 0 |
| 30 Jun 21 | 1,295 | 112 | 379 | 0 |
| 31 Mar 21 | 1,160 | 83 | 339 | 0 |
| 01 Jan 21 | 1,087 | 57 | 323 | 0 |
| 30 Sep 20 | 1,033 | 36 | 295 | 0 |
| 30 Jun 20 | 974 | 16 | 289 | 0 |
| 31 Mar 20 | 1,007 | 18 | 307 | 0 |
| 31 Dec 19 | 975 | 14 | 300 | 0 |
| 30 Sep 19 | 939 | 20 | 311 | 0 |
| 30 Jun 19 | 902 | 16 | 304 | 0 |
| 31 Mar 19 | 861 | 11 | 365 | 0 |
| 01 Jan 19 | 804 | 13 | 290 | 0 |
| 30 Sep 18 | 745 | 8 | 284 | 0 |
| 30 Jun 18 | 699 | 5 | 277 | 0 |
| 31 Mar 18 | 657 | 5 | 265 | 0 |
| 01 Jan 18 | 628 | 4 | 265 | 0 |
| 30 Sep 17 | 610 | 3 | 261 | 0 |
| 30 Jun 17 | 577 | -2 | 256 | 0 |
| 31 Mar 17 | 539 | -6 | 227 | 0 |
| 01 Jan 17 | 508 | -5 | 227 | 0 |
| 30 Sep 16 | 469 | -1 | 214 | 0 |
| 31 Dec 15 | 396 | 9 | 165 | 0 |
| 31 Dec 14 | 337 | 7 | 143 | 0 |
Quality Earnings: M has high quality earnings.
Growing Profit Margin: M became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: M's earnings have declined by 15.4% per year over the past 5 years.
Accelerating Growth: M has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: M has become profitable in the last year, making it difficult to compare its past year earnings growth to the Healthcare industry (15.5%).
Return on Equity
High ROE: M's Return on Equity (2.5%) is considered low.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/17 09:04 |
| End of Day Share Price | 2025/01/17 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Med Life S.A. is covered by 6 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Caius Rapanu | Erste Group Bank AG |
| Catalin Diaconu | Raiffeisen Bank International AG - Institutional Equity |
| Maria Magherusan | SSIF BRK Financial Group S.A. |